Andreas Stahl Selected Research

Ranibizumab (Lucentis)

5/2024	Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): five-year outcomes of a randomised trial.
1/2023	Assessment of Retinopathy of Prematurity Regression and Reactivation Using an Artificial Intelligence-Based Vascular Severity Score.
3/2022	Observational outcomes in proliferative diabetic retinopathy patients following treatment with ranibizumab, panretinal laser photocoagulation or combination therapy - The non-interventional second year follow-up to the PRIDE study.
2/2022	Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study.
1/2022	Time Course of Retinopathy of Prematurity Regression and Reactivation After Treatment with Ranibizumab or Laser in the RAINBOW Trial.
10/2021	2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial.
8/2020	Efficacy and safety of ranibizumab with or without panretinal laser photocoagulation versus laser photocoagulation alone in proliferative diabetic retinopathy - the PRIDE study.
1/2020	Ranibizumab Population Pharmacokinetics and Free VEGF Pharmacodynamics in Preterm Infants With Retinopathy of Prematurity in the RAINBOW Trial.
10/2019	Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial.
1/2018	Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity: A Randomized Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas Stahl Research Topics

Disease

29	Retinopathy of Prematurity (Retrolental Fibroplasia) 05/2024 - 01/2009
12	Pathologic Neovascularization 03/2024 - 01/2009
12	Obesity 01/2022 - 03/2005
11	Neoplasms (Cancer) 04/2024 - 08/2008
11	Retinal Neovascularization 04/2024 - 08/2010
9	Macular Degeneration (Age-Related Maculopathy) 01/2023 - 09/2010
9	Retinal Vein Occlusion 01/2023 - 10/2007
8	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2023 - 01/2009
7	Retinal Diseases 01/2023 - 04/2009
7	Insulin Resistance 01/2022 - 03/2004
6	Inflammation (Inflammations) 01/2021 - 10/2012
6	Weight Gain 12/2016 - 12/2010
5	Birth Weight (Birth Weights) 05/2024 - 10/2019
5	Myopia 05/2024 - 10/2015
5	Hypoxia (Hypoxemia) 01/2015 - 10/2007
4	Blindness (Hysterical Blindness) 01/2023 - 05/2012
4	Wounds and Injuries (Trauma) 01/2023 - 06/2005
4	Type 2 Diabetes Mellitus (MODY) 12/2022 - 02/2004
4	Eye Diseases (Eye Disease) 01/2020 - 11/2011
4	Non-alcoholic Fatty Liver Disease 01/2018 - 08/2008
4	Macular Edema 01/2018 - 10/2007
3	Coenzyme Q10 Deficiency 01/2024 - 02/2015
3	Body Weight (Weight, Body) 01/2022 - 04/2006
3	Epiretinal Membrane (Epiretinal Membranes) 01/2022 - 09/2014
3	Choroidal Neovascularization 01/2020 - 04/2009
3	Fatty Liver 02/2014 - 02/2004
2	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 11/2022
2	Retinal Detachment (Retinal Detachments) 04/2024 - 06/2023
2	Melanoma (Melanoma, Malignant) 07/2023 - 11/2022
2	Pathologic Processes 01/2023 - 08/2006
2	Disease Progression 01/2023 - 11/2014
2	Neoplasm Metastasis (Metastasis) 11/2022 - 08/2008
2	Vascular Diseases (Vascular Disease) 03/2022 - 01/2016
2	Retinal Perforations 01/2021 - 09/2014
2	Telangiectasis (Telangiectasia) 01/2020 - 01/2016
2	Ischemia 01/2020 - 10/2013
2	Hyperoxia 09/2013 - 01/2009
1	Hypertension (High Blood Pressure) 02/2024
1	Neuroblastoma 02/2024
1	Premature Birth (Birth, Premature) 10/2023
1	Melanosis (Freckles) 07/2023
1	Refractive Errors (Refractive Error) 06/2023
1	Strabismus (Squint) 06/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2022

Drug/Important Bio-Agent (IBA)

28	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2024 - 10/2007
21	Retinaldehyde (Retinal)IBA 10/2023 - 04/2009
18	Fatty Acids (Saturated Fatty Acids)IBA 02/2024 - 05/2003
13	Oxygen (Dioxygen)IBA 01/2020 - 01/2009
11	LipidsIBA 01/2018 - 05/2003
10	Ranibizumab (Lucentis)FDA Link 05/2024 - 01/2018
9	Insulin (Novolin)FDA Link 01/2022 - 02/2004
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2008
7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2004
6	Fatty Acid Transport Proteins (Fatty Acid Transport Protein)IBA 07/2016 - 03/2004
5	RNA (Ribonucleic Acid)IBA 10/2022 - 03/2013
4	afliberceptIBA 04/2024 - 01/2022
4	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 09/2016 - 02/2011
4	Triglycerides (Triacylglycerol)IBA 01/2016 - 06/2005
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2020
3	Bevacizumab (Avastin)FDA Link 01/2010 - 10/2007
2	HydrogelsIBA 04/2024 - 05/2016
2	Phosphotransferases (Kinase)IBA 01/2024 - 03/2013
2	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2019
2	Nerve Growth Factors (Neurotrophins)IBA 01/2020 - 01/2016
2	Ciliary Neurotrophic Factor (CNTF)IBA 01/2020 - 01/2016
2	CopperIBA 10/2018 - 12/2016
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2018 - 08/2015
2	MetalsIBA 11/2017 - 12/2016
2	Dietary Fats (Dietary Fat)IBA 01/2016 - 02/2014
2	VLDL LipoproteinsIBA 08/2015 - 04/2011
2	CytokinesIBA 08/2015 - 10/2012
2	AdiponectinIBA 10/2014 - 03/2004
2	PPAR gammaIBA 01/2013 - 08/2010
2	Transcription Factors (Transcription Factor)IBA 01/2013 - 11/2012
2	Bile Acids and Salts (Bile Acids)IBA 10/2012 - 04/2006
1	Hyaluronic Acid (Hyaluronan)IBA 04/2024
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 03/2024
1	SteroidsIBA 02/2024
1	LuciferinsIBA 02/2024
1	Nonesterified Fatty Acids (NEFA)IBA 02/2024
1	fibroblast growth factor 21IBA 01/2024
1	Ophthalmic Solutions (Eye Drops)IBA 07/2023
1	Cytostatic AgentsIBA 07/2023
1	Adenosine Triphosphate (ATP)IBA 12/2022
1	Adenosine Diphosphate (ADP)IBA 12/2022
1	coenzyme Q10 (CoQ10)IBA 12/2022
1	Uncoupling Protein 1IBA 12/2022

Therapy/Procedure

12	Lasers (Laser) 05/2024 - 01/2013
11	Therapeutics 11/2022 - 08/2008
7	Laser Therapy (Surgery, Laser) 05/2024 - 10/2015
5	Intravitreal Injections 02/2024 - 01/2020
4	Injections 04/2024 - 04/2009
4	Light Coagulation 01/2024 - 08/2020
4	Aftercare (After-Treatment) 06/2023 - 01/2019
3	Retreatment 12/2023 - 10/2019
2	Erythrocyte Transfusion 12/2023 - 12/2023
2	Immunotherapy 11/2022 - 10/2022
2	Vitrectomy 01/2021 - 09/2014
1	Prenatal Care (Care, Prenatal) 10/2023
1	Off-Label Use 07/2023